| Nome |
# |
|
Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments., file e268c4ca-7d7a-a6b7-e053-3a05fe0adea1
|
123
|
|
Systemic sclerosis: state of the art on clinical practice guidelines, file e268c4ca-d524-a6b7-e053-3a05fe0adea1
|
120
|
|
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages., file e268c4ca-fd13-a6b7-e053-3a05fe0adea1
|
114
|
|
Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages, file e268c4ca-3847-a6b7-e053-3a05fe0adea1
|
108
|
|
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts, file e268c4ca-7b96-a6b7-e053-3a05fe0adea1
|
108
|
|
CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production., file e268c4c5-f662-a6b7-e053-3a05fe0adea1
|
107
|
|
Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon, file e268c4ca-8114-a6b7-e053-3a05fe0adea1
|
107
|
|
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay, file e268c4ca-47bc-a6b7-e053-3a05fe0adea1
|
103
|
|
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement., file e268c4ca-4f59-a6b7-e053-3a05fe0adea1
|
96
|
|
White matter hyperintensities on brain magnetic resonance in systemic sclerosis, file e268c4c7-8979-a6b7-e053-3a05fe0adea1
|
95
|
|
Blunted coronary flow reserve in systemic sclerosis: a sign of cardiac involvement in asymptomatic patients, file e268c4c6-1d08-a6b7-e053-3a05fe0adea1
|
94
|
|
Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison., file e268c4c6-1281-a6b7-e053-3a05fe0adea1
|
90
|
|
Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis, file e268c4c8-261d-a6b7-e053-3a05fe0adea1
|
86
|
|
An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases, file e268c4ca-d252-a6b7-e053-3a05fe0adea1
|
84
|
|
Fast track algorithm: How to differentiate a "scleroderma pattern" from a "non-scleroderma pattern"., file e268c4cb-3d64-a6b7-e053-3a05fe0adea1
|
83
|
|
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis, file e268c4cc-14de-a6b7-e053-3a05fe0adea1
|
79
|
|
Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis., file e268c4ca-29c8-a6b7-e053-3a05fe0adea1
|
73
|
|
Microvascular damage evaluation in systemic sclerosis: the role of nailfold videocapillaroscopy and laser techniques., file e268c4ca-2a28-a6b7-e053-3a05fe0adea1
|
54
|
|
Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study, file e268c4ca-6d72-a6b7-e053-3a05fe0adea1
|
49
|
|
Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: a systematic review and international Delphi consensus., file e268c4cd-de3c-a6b7-e053-3a05fe0adea1
|
41
|
|
Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system., file e268c4cd-c34e-a6b7-e053-3a05fe0adea1
|
38
|
|
Body Composition and Bone Status in Relation to Microvascular Damage in Systemic Sclerosis Patients, file e268c4cc-868c-a6b7-e053-3a05fe0adea1
|
15
|
|
Ehlers-Danlos syndromes: state of the art on clinical practice guidelines., file e268c4ca-30db-a6b7-e053-3a05fe0adea1
|
14
|
|
Apremilast interferes with the TGFβ1-induced transition of human skin fibroblasts into profibrotic myofibroblasts: in vitro study, file e268c4cc-d41a-a6b7-e053-3a05fe0adea1
|
11
|
|
Update of EULAR recommendations for the treatment of systemic sclerosis., file e268c4ca-bfdc-a6b7-e053-3a05fe0adea1
|
7
|
|
Methods for the morphological and functional evaluation of microvascular damage in systemic sclerosis, file e268c4ca-97e2-a6b7-e053-3a05fe0adea1
|
6
|
|
Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings, file e268c4cd-de37-a6b7-e053-3a05fe0adea1
|
6
|
|
Metabolic Profile and Bone Status in Post-Menopausal Women with Rheumatoid Arthritis: A Monocentric Retrospective Survey, file e268c4cd-ea34-a6b7-e053-3a05fe0adea1
|
6
|
|
Nutritional Status and Bone Microarchitecture in a Cohort of Systemic Sclerosis Patients, file e268c4cc-b723-a6b7-e053-3a05fe0adea1
|
5
|
|
POS0933 NAILFOLD VIDEOCAPILLAROSCOPY AS A POSSIBLE BIOMARKER TO DETECT ABERRANT PLACENTAL MICROCIRCULATION IN PREGNANT WOMEN: A PILOT STUDY, file ec41dd56-f0b5-484a-98b4-4b11145b0bdf
|
5
|
|
Correction: Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity, file 6f49247f-59ee-46a1-8125-a58ad6c047c8
|
4
|
|
Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis., file e268c4c5-f4e2-a6b7-e053-3a05fe0adea1
|
4
|
|
Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis, file e268c4c8-5211-a6b7-e053-3a05fe0adea1
|
4
|
|
Brachial Artery Endothelial-dependent Flow-mediated Dilation Identifies Early-stage Endothelial Dysfunction in Systemic Sclerosis and Correlates with Nailfold Microvascular Impairment, file e268c4c8-6095-a6b7-e053-3a05fe0adea1
|
4
|
|
Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients., file e268c4ca-2294-a6b7-e053-3a05fe0adea1
|
4
|
|
Nailfold capillaroscopy-how many fingers should be examined to detect abnormality?, file e268c4ca-38a7-a6b7-e053-3a05fe0adea1
|
4
|
|
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis, file e268c4ca-4f66-a6b7-e053-3a05fe0adea1
|
4
|
|
Progression of Organ Involvement in Systemic Sclerosis Patients with Persistent "Late" Nailfold Capillaroscopic Pattern of Microangiopathy: A Prospective Study., file e268c4ca-5980-a6b7-e053-3a05fe0adea1
|
4
|
|
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey)., file e268c4ca-9835-a6b7-e053-3a05fe0adea1
|
4
|
|
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database., file e268c4ca-a2d6-a6b7-e053-3a05fe0adea1
|
4
|
|
Cross-cultural adaptation and validity of the Italian version of the Central Sensitization Inventory, file e268c4ca-d52c-a6b7-e053-3a05fe0adea1
|
4
|
|
Pregnancy, cytokines and disease activity in systemic lupus erythematosus, file e268c4c5-ec4b-a6b7-e053-3a05fe0adea1
|
3
|
|
Role of estrogens in inflammatory response: expression of estrogen receptors in peritoneal fluid macrophages from endometriosis, file e268c4c5-f80b-a6b7-e053-3a05fe0adea1
|
3
|
|
Vitamin D, steroid hormones, and autoimmunity., file e268c4c6-ca4f-a6b7-e053-3a05fe0adea1
|
3
|
|
The assessment of nailfold capillaries: comparison of dermoscopy and nailfold videocapillaroscopy, file e268c4ca-499b-a6b7-e053-3a05fe0adea1
|
3
|
|
CTLA-4 blockade in the treatment of rheumatoid arthritis: an update, file e268c4ca-49a3-a6b7-e053-3a05fe0adea1
|
3
|
|
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study, file e268c4ca-4fdd-a6b7-e053-3a05fe0adea1
|
3
|
|
Quantitative Alterations of Capillary Diameter Have a Predictive Value for Development of the Capillaroscopic Systemic Sclerosis Pattern, file e268c4ca-6f85-a6b7-e053-3a05fe0adea1
|
3
|
|
Primary Raynaud's phenomenon and nailfold videocapillaroscopy: age-related changes in capillary morphology., file e268c4ca-7de7-a6b7-e053-3a05fe0adea1
|
3
|
|
Capillaroscopy In Routine Diagnostics: Potentials And Limitations, file e268c4ca-9ce4-a6b7-e053-3a05fe0adea1
|
3
|
|
Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study., file e268c4ca-d261-a6b7-e053-3a05fe0adea1
|
3
|
|
Air Travel, Circadian Rhythms/Hormones, and Autoimmunity., file e268c4ca-d8df-a6b7-e053-3a05fe0adea1
|
3
|
|
Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients, file e268c4ca-f78c-a6b7-e053-3a05fe0adea1
|
3
|
|
Long-term follow-up of nailfold videocapillaroscopic microvascular parameters in mixed connective tissue disease versus systemic sclerosis patients: a retrospective cohort study., file e268c4cb-4881-a6b7-e053-3a05fe0adea1
|
3
|
|
Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database, file e268c4cc-6938-a6b7-e053-3a05fe0adea1
|
3
|
|
The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET, file e268c4cd-80a9-a6b7-e053-3a05fe0adea1
|
3
|
|
Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity, file e268c4cd-bab4-a6b7-e053-3a05fe0adea1
|
3
|
|
Vitamin D and Lung Outcomes in Elderly COVID-19 Patients, file e268c4ce-00a3-a6b7-e053-3a05fe0adea1
|
3
|
|
Engineered glove to evaluate hand disability in rheumatoid arthritis: A pilot-study, file e268c4ce-5d56-a6b7-e053-3a05fe0adea1
|
3
|
|
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products, file 15d81958-aca4-42d9-864c-63a9ac3ed0b8
|
2
|
|
Microvascular damage in autoimmune connective tissue diseases: a capillaroscopic analysis from 20 years of experience in a EULAR training and research referral centre for imaging, file 43accdd7-7aea-4e98-9184-e66b53fabc3d
|
2
|
|
The dichotomy of glucocorticosteroid treatment in immuneinflammatory rheumatic diseases: an evidence-based perspective and insights from clinical practice, file 54870051-20b5-4dd5-a24a-08e533ca0413
|
2
|
|
Vitamin D and COVID-19: Narrative Review after 3 Years of Pandemic, file 58fe0dc8-8a31-48e5-a70c-e9557b676b1d
|
2
|
|
Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients, file e268c4c5-f4e1-a6b7-e053-3a05fe0adea1
|
2
|
|
Anti-TNF and sex hormones, file e268c4c6-115b-a6b7-e053-3a05fe0adea1
|
2
|
|
Correlations between nailfold microangiopathy severity, finger dermal thickness and fingertip blood perfusion in systemic sclerosis patients, file e268c4c6-c0ca-a6b7-e053-3a05fe0adea1
|
2
|
|
Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages, file e268c4ca-2ae3-a6b7-e053-3a05fe0adea1
|
2
|
|
Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis, file e268c4ca-2ba8-a6b7-e053-3a05fe0adea1
|
2
|
|
Quantitative outcome measures for systemic sclerosis-related Microangiopathy - Reliability of image acquisition in Nailfold Capillaroscopy., file e268c4ca-38af-a6b7-e053-3a05fe0adea1
|
2
|
|
Intra-and inter-observer reliability of nailfold videocapillaroscopy - A possible outcome measure for systemic sclerosis-related microangiopathy., file e268c4ca-4656-a6b7-e053-3a05fe0adea1
|
2
|
|
Nailfold capillaroscopic parameters and skin telangiectasia patterns in patients with systemic sclerosis., file e268c4ca-4661-a6b7-e053-3a05fe0adea1
|
2
|
|
Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells, file e268c4ca-49a1-a6b7-e053-3a05fe0adea1
|
2
|
|
Capillaroscopy 2016: new perspectives in systemic sclerosis., file e268c4ca-4a12-a6b7-e053-3a05fe0adea1
|
2
|
|
Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients, file e268c4ca-4b7f-a6b7-e053-3a05fe0adea1
|
2
|
|
Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis., file e268c4ca-4bf6-a6b7-e053-3a05fe0adea1
|
2
|
|
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study, file e268c4ca-5308-a6b7-e053-3a05fe0adea1
|
2
|
|
Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients, file e268c4ca-5798-a6b7-e053-3a05fe0adea1
|
2
|
|
Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: Proof of principle and validation in systemic sclerosis, file e268c4ca-70fa-a6b7-e053-3a05fe0adea1
|
2
|
|
Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients, file e268c4ca-8116-a6b7-e053-3a05fe0adea1
|
2
|
|
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study., file e268c4ca-aa59-a6b7-e053-3a05fe0adea1
|
2
|
|
European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO)., file e268c4ca-bd13-a6b7-e053-3a05fe0adea1
|
2
|
|
Testing the anti-osteoclastic function of biologic DMARDs, file e268c4ca-d52a-a6b7-e053-3a05fe0adea1
|
2
|
|
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis, file e268c4ca-d700-a6b7-e053-3a05fe0adea1
|
2
|
|
Systemic sclerosis: markers and targeted treatments, file e268c4ca-d8e1-a6b7-e053-3a05fe0adea1
|
2
|
|
Reliability of the quantitative assessment of peripheral blood perfusion by laser speckle contrast analysis in a systemic sclerosis cohort, file e268c4ca-daa0-a6b7-e053-3a05fe0adea1
|
2
|
|
Therapy. Optimized treatment algorithms for digital vasculopathy in SSc., file e268c4ca-fb1d-a6b7-e053-3a05fe0adea1
|
2
|
|
Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study, file e268c4ca-fd1d-a6b7-e053-3a05fe0adea1
|
2
|
|
Progression of nailfold capillaroscopic patterns and correlation with organ involvement in systemic sclerosis: a 12 year study., file e268c4cb-4ca2-a6b7-e053-3a05fe0adea1
|
2
|
|
The impact of transducer frequency in ultrasound evaluation of subclinical skin involvement in limited cutaneous systemic sclerosis patients., file e268c4cb-51b9-a6b7-e053-3a05fe0adea1
|
2
|
|
Comment on: Lower urinary tract symptoms in systemic sclerosis patients: a detailed investigation: reply., file e268c4cc-220a-a6b7-e053-3a05fe0adea1
|
2
|
|
Peripheral blood perfusion in patients with systemic lupus erythematosus and in primary Raynaud's phenomenon., file e268c4cc-f938-a6b7-e053-3a05fe0adea1
|
2
|
|
CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients, file e268c4ce-7236-a6b7-e053-3a05fe0adea1
|
2
|
|
Nailfold capillaroscopy in the rheumatological current clinical practice in Italy: results of a national survey, file f7e3532d-b2ab-42e4-ba75-f1f8dae3b680
|
2
|
|
Emerging nailfold capillaroscopic patterns in COVID-19: from acute patients to survivors, file 23d0bcbb-49ec-499a-8c02-314e43d4712c
|
1
|
|
A Systematic Review of Aminaphtone from Pathophysiology to Clinical Applications: Focus on New Rheumatological Acquisitions, file 5a461afb-e2ea-4e7f-be30-85ba54b0d888
|
1
|
|
Nailfold capillaroscopy, file 7e058cb1-9514-4376-8502-a50e87ee6967
|
1
|
|
Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update, file bf17dcaa-e715-42ea-82c7-2e3213953b72
|
1
|
|
Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET., file d8a16c7f-1556-4901-999d-5f2e3a984b17
|
1
|
|
Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis., file e268c4c5-f4d3-a6b7-e053-3a05fe0adea1
|
1
|
|
null, file e268c4c6-09ea-a6b7-e053-3a05fe0adea1
|
1
|
| Totale |
2.100 |